Anne Schepers
Wilrijk, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.
Journal: Molecular oncology
Published: September 23, 2025
IMPRESS: Improved methylation profiling using restriction enzymes and smMIP sequencing, combined with a new biomarker panel, creating a multi-cancer detection assay.
Journal: British journal of cancer
Published: February 12, 2024
CRISPR/Cas9-edited ROS1 + non-small cell lung cancer cell lines highlight differential drug sensitivity in 2D vs 3D cultures while reflecting established resistance profiles.
Journal: Journal of translational medicine
Published: November 10, 2023
Epigenome-wide methylation analysis of colorectal carcinoma, adenoma and normal tissue reveals novel biomarkers addressing unmet clinical needs.
Journal: Clinical epigenetics
Published: March 22, 2023
Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence.
Journal: International journal of molecular sciences
Published: September 29, 2021
Insufficient evidence for a role of SERPINF1 in otosclerosis.
Journal: Molecular genetics and genomics : MGG
Published: September 14, 2018
Variants affecting diverse domains of MEPE are associated with two distinct bone disorders, a craniofacial bone defect and otosclerosis.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: April 03, 2018
The splicing mutant of the human tumor suppressor protein DFNA5 induces programmed cell death when expressed in the yeast Saccharomyces cerevisiae.
Journal: Frontiers in oncology
Published: April 03, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026